Search Results 601-610 of 17148 for treatment resistant depression
... Refractory Kidney Pain. Rochester, Minn. The purpose of this study is to examine patient reported outcomes including pain, quality of life, depression and ...
D., at Mayo Clinic studies the mechanism of action of targeted anti-cancer agents and the factors that affect tumor cell sensitivity and resistance. Most ...
Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...
Teen depression · Teen drug abuse · Nutrition and pain · Pain rehabilitation · Self-care approaches to treating pain · Treatment-resistant depression ...
This multicenter, open-label, dose-escalating study will assess the safety and efficacy of DFRF4539A in patients with relapsed or refractory multiple myeloma.
The purpose of this study is to evaluate the efficacy and safety of 2 daratumumab treatment regimens in participants with multiple myeloma who have received at ...
Cognitive behavioral therapy for depressive disorders: Outcomes from a multi-state, multi-site primary care practice. J Affect Disord. 2021 Nov 01; 294:745-752.
A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma · Share · Facebook ...
... treatment) or other treatments. This medicine is ... Throw away used needles in a hard, closed container (puncture-resistant) that the needles cannot poke through ...
Clinical Trials · A Study to Evaluate MEDI2228 in Subjects with Relapsed/ Refractory Multiple Myeloma · More about research at Mayo Clinic · Mayo Clinic Footer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.